RxDoctor Payments Data

William Obremskey, MD

Orthopaedic Trauma · Nashville, TNNPI 1770670887

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 95.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $4,770 and has fallen 75.2% since, to $1,183 in 2025.

$13,861in general payments, 2019–2025

Across 23 payments — averaging $602.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$13K
  • Davol Inc.$248
  • Bone Support Inc.$154
  • Illuminoss Medical, Inc.$147
  • My01 Inc.$94
  • Stryker$32
  • plus $16 from 1 others
$82,821in research payments, 2019–2025

Across 21 payments — averaging $3943.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • BONE Support AB$83K

What the payments were for

  • Consulting fees$7505%
  • Speaking & faculty fees$6,47147%
  • Travel & lodging$5,95043%
  • Food & beverage$6905%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Synthes GmbH16$13,171
Davol Inc.2$248
Bone Support Inc.1$154
Illuminoss Medical, Inc.1$147
My01 Inc.1$94
Stryker1$32
Orthofix Medical, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,861 in reported general payments places this provider in the 70th percentile of 27 orthopaedic trauma providers in Tennessee.

See all orthopaedic trauma providers in Tennessee

Medicare billing

Part B allowed, 2024
$47,912
Medicare patients
77
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin12$97

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →